BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29349060)

  • 1.
    Mosey H; Núñez JA; Goring A; Clarkin CE; Staines KA; Lee PD; Pitsillides AA; Javaheri B
    Front Mater; 2017 Sep; 4():27. PubMed ID: 29349060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing.
    Javaheri B; Carriero A; Staines KA; Chang YM; Houston DA; Oldknow KJ; Millan JL; Kazeruni BN; Salmon P; Shefelbine S; Farquharson C; Pitsillides AA
    Bone; 2015 Dec; 81():277-291. PubMed ID: 26232374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
    Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
    J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
    Ryan ZC; Ketha H; McNulty MS; McGee-Lawrence M; Craig TA; Grande JP; Westendorf JJ; Singh RJ; Kumar R
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6199-204. PubMed ID: 23530237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formation.
    Nakamura K; Koide M; Kobayashi Y; Yamashita T; Matsushita M; Yasuda H; Ishihara Y; Yoshinari N; Udagawa N
    J Periodontal Res; 2023 Aug; 58(4):769-779. PubMed ID: 37154419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.
    Yang H; Büttner A; Albiol L; Julien C; Thiele T; Figge C; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
    Sci Rep; 2020 Dec; 10(1):22299. PubMed ID: 33339872
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Albiol L; Cilla M; Pflanz D; Kramer I; Kneissel M; Duda GN; Willie BM; Checa S
    J R Soc Interface; 2018 Apr; 15(141):. PubMed ID: 29669893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
    Qin W; Zhao W; Li X; Peng Y; Harlow LM; Li J; Qin Y; Pan J; Wu Y; Ran L; Ke HZ; Cardozo CP; Bauman WA
    Osteoporos Int; 2016 Dec; 27(12):3627-3636. PubMed ID: 27436301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant sclerostin inhibits bone formation
    Dreyer T; Shah M; Doyle C; Greenslade K; Penney M; Creeke P; Kotian A; Ke HZ; Naidoo V; Holdsworth G
    J Orthop Translat; 2021 Jul; 29():134-142. PubMed ID: 34249611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
    Li C; Wang W; Xie L; Luo X; Cao X; Wan M
    Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of estrogen deficiency on cortical bone microporosity and mineralization.
    Sharma D; Larriera AI; Palacio-Mancheno PE; Gatti V; Fritton JC; Bromage TG; Cardoso L; Doty SB; Fritton SP
    Bone; 2018 May; 110():1-10. PubMed ID: 29357314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.
    Chang MK; Kramer I; Huber T; Kinzel B; Guth-Gundel S; Leupin O; Kneissel M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5187-95. PubMed ID: 25404300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.
    Li C; Ominsky MS; Tan HL; Barrero M; Niu QT; Asuncion FJ; Lee E; Liu M; Simonet WS; Paszty C; Ke HZ
    Bone; 2011 Dec; 49(6):1178-85. PubMed ID: 21890008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strength.
    Morse A; Yu NY; Peacock L; Mikulec K; Kramer I; Kneissel M; McDonald MM; Little DG
    Bone; 2015 Feb; 71():155-63. PubMed ID: 25445453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Long-Term Sclerostin Deficiency on Trabecular Bone Mass and Adaption to Limb Loading Differ in Male and Female Mice.
    Albiol L; Büttner A; Pflanz D; Mikolajewicz N; Birkhold AI; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
    Calcif Tissue Int; 2020 Apr; 106(4):415-430. PubMed ID: 31873756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
    Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
    Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.